APA (7th ed.) Citation

S, O., O, K., U, O., YE, A., D, I., H, S., . . . N, T. (2025). Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine. Medicina (Kaunas, Lithuania), 61(5), . https://doi.org/10.3390/medicina61050819

Chicago Style (17th ed.) Citation

S, Oksuz, et al. "Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine." Medicina (Kaunas, Lithuania) 61, no. 5 (2025). https://doi.org/10.3390/medicina61050819.

MLA (9th ed.) Citation

S, Oksuz, et al. "Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine." Medicina (Kaunas, Lithuania), vol. 61, no. 5, 2025, https://doi.org/10.3390/medicina61050819.